Insmed INSM United Kingdom — Operating loss carryforwards
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.
The source filing: Insmed’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 7:01 AM EST
- Fiscal year
- FY2025
- Accession
- 0001104506-26-000009
At December 31, 2025, the Company had federal net operating loss (NOL) carryforwards for income tax purposes of approximately $3.3 billion and federal tax credit carryforwards of $270.1 million. Due to the limitation on NOLs as more fully discussed below, $3.1 billion of the NOLs are available to offset future taxable income, if any. The NOL carryovers and general business tax credits expire in various years beginning in 2026. For state tax purposes, the Company has approximately $2.1 billion of NOLs in various states available to offset against future taxable income and state tax credit carryforwards of $23.1 million, expiring in various years beginning in 2026. The Company has $301.1 million of non-trading loss carryforwards in Ireland and loss carryforwards in the UK and Switzerland of $95.7 million and $277.1 million, respectively. The loss carryforwards in Ireland and the UK carry forward indefinitely while the loss carryforward in Switzerland begins to expire in 2030. The Company has disallowed interest expense carryover of $47.7 million which carries forward indefinitely.
ITEM 16. FORM 10-K SUMMARY
FAQ
- What is Insmed's united kingdom — operating loss carryforwards?
- Insmed (INSM) reported united kingdom — operating loss carryforwards of $95.7M in Q4 2025.
- What does united kingdom — operating loss carryforwards mean?
- This metric represents the accumulated tax losses generated by the company's operations within the United Kingdom that are available to offset future taxable income in that jurisdiction. It serves as a deferred tax asset that can reduce future corporate tax liabilities, thereby improving cash flow and net income. Investors monitor this figure to assess the potential tax shield benefits and the long-term fiscal efficiency of the company's UK-based business activities.
Ask your AI about Insmed's united kingdom — operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
